Abstract:Oral insulin delivery has received the most attention in insulin formulations due to its high patient compliance and, more importantly, to its potential to mimic the physiologic insulin secretion seen in non-diabetic individuals. However, oral insulin delivery has two major limitations: the enzymatic barrier that leads to rapid insulin degradation, and the mucosal barrier that limits insulin’s bioavailability. Several approaches have been actively pursued to circumvent the enzyme barrier, with some of them receiving promising results. Yet, thus far there has been no major success in overcoming the mucosal barrier, which is the main cause in undercutting insulin’s oral bioavailability. In this review of our group’s research, an innovative silica-based, mucoadhesive oral insulin formulation with encapsulated-insulin/cell penetrating peptide (CPP) to overcome both enzyme and mucosal barriers is discussed, and the preliminary and convincing results to confirm the plausibility of this oral insulin delivery system are reviewed. In vitro studies demonstrated that the CPP-insulin conjugates could facilitate cellular uptake of insulin while keeping insulin’s biologic functions intact. It was also confirmed that low molecular weight protamine (LMWP) behaves like a CPP peptide, with a cell translocation potency equivalent to that of the widely studied TAT. The mucoadhesive properties of the produced silica-chitosan composites could be controlled by varying both the pH and composition; the composite consisting of chitosan (25 wt-%) and silica (75 wt-%) exhibited the greatest mucoadhesion at gastric pH. Furthermore, drug release from the composite network could also be regulated by altering the chitosan content. Overall, the universal applicability of those technologies could lead to development of a generic platform for oral delivery of many other bioactive compounds, especially for peptide or protein drugs which inevitably encounter the poor bioavailability issues.

Mucoadhesive Ionic Liquid Gel Patches for Oral Delivery

PEGylated insulin loaded complexation hydrogels for protected oral delivery

Enhanced Transdermal Delivery of Insulin by Choline-Based Ionic Liquids

Bioadhesive Fluorescent Microspheres As Visible Carriers For Local Delivery Of Drugs. Ii: Uptake Of Insulin-Loaded Pcefb/Plga Microspheres By The Gastrointestinal Tract

Choline geranate (CAGE): A multifaceted ionic liquid for drug delivery

Development, characterization, and evaluation of polymer-based hydrogel membrane patches for intestinal delivery of gliclazide

Ionic Liquids: Promising Approach for Oral Drug Delivery

Intestinal-Target and Glucose-Responsive Smart Hydrogel toward Oral Delivery System of Drug with Improved Insulin Utilization

Oral Delivery of Insulin by Barbed Microneedles Actuated by Intestinal Peristalsis

Development of gliclazide ionic liquid and the transdermal patches: An effective and noninvasive sustained release formulation to achieve hypoglycemic effects

Overcoming Oral Insulin Delivery Barriers: Application of Cell Penetrating Peptide and Silica-Based Nanoporous Composites

Ionic Liquid-Based patch formulation for enhanced transdermal delivery of sparingly soluble drug

Enhancing the Solubility and Transdermal Delivery of Drugs Using Ionic Liquid‐In‐Oil Microemulsions

Single-Cell Oral Delivery Platform for Enhanced Acid Resistance and Intestinal Adhesion

Enhancing Insulin Oral Absorption by Using Mucoadhesive Nanoparticles Loaded with LMWP-linked Insulin Conjugates.

Beneficial Properties for Insulin Absorption Using Superporous Hydrogel Containing Interpenetrating Polymer Network As Oral Delivery Vehicles

Noninvasive and Efficient Peptide Delivery by a Novel Biocompatible Ionic Liquid

Topical systems for the controlled release of antineoplastic Drugs: Oxidized Alginate-Gelatin Hydrogel/Unilamellar vesicles

Ionic liquids for oral insulin delivery

Mechanism and performance of choline-based ionic liquids in enhancing nasal delivery of glucagon

Oral Ionic Liquid for Transdermal Delivery and Obesity Treatment